Regenxbio RGNX
NASDAQ RGNX
$8.94 -0.26 (-2.83%)
As of: Sep 4, 2026 · 3:59 PM EDT

Regenxbio (RGNX) Operating Margin (QoQ) (2014 - 2025)

Analysis

Regenxbio (RGNX) Operating Margin (QoQ) (2014 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Regenxbio 472.74 Mn 367.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1,371.00
Sep 30, 2025 11,999.00
Jun 30, 2025 -30,988.00
Mar 31, 2025 25,577.00
Dec 31, 2024 1,441.00
Sep 30, 2024 -521.00
Jun 30, 2024 15,746.00
Mar 31, 2024 -12,112.00
Dec 31, 2023 -6,302.00
Sep 30, 2023 14,129.00
Jun 30, 2023 -2,028.00
Mar 31, 2023 -16,138.00
Dec 31, 2022 8,367.00
Sep 30, 2022 -7,644.00
Jun 30, 2022 13,040.00
Mar 31, 2022 -40,060.00
Dec 31, 2021 26,502.00
Sep 30, 2021 5,066.00
Jun 30, 2021 -379.00
Mar 31, 2021 1,696.00